Novartis CEO disheartened by Germany’s planned €60B cuts to healthcare spending

Vas Narasimhan, Novartis CEO (Gian Ehrenzeller/Keystone via AP Images) April 28, 2026 06:35 AM EDTUpdated 01:44 PM Pharma No­var­tis CEO dis­heart­ened by Ger­many’s planned €60B cuts to health­care spend­ing Ayisha Sharma News Reporter No­var­tis CEO Vas Narasimhan said the Swiss com­pa­ny is “very dis­ap­point­ed” by Ger­many’s plan to shave off more than €60 bil­lion in health­care costs that … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER